2348 fundamentals
An in-depth look to DAWNRAYS PHARMACEUTICAL HLDGS operating, investing, and financing activities
2348 free cash flow for H2 24 is 67.71 M HKD. For 2024, 2348 free cash flow was 142.86 M HKD and operating cash flow was 279.52 M HKD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM